Statements in which the resource exists.
SubjectPredicateObjectContext
pubmed-article:15128762rdf:typepubmed:Citationlld:pubmed
pubmed-article:15128762lifeskim:mentionsumls-concept:C0005821lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0600431lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0021467lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C1306235lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C1335280lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C1706044lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C1514562lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0679058lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0021469lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0152060lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C1547699lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C2349975lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C2700640lld:lifeskim
pubmed-article:15128762lifeskim:mentionsumls-concept:C0205154lld:lifeskim
pubmed-article:15128762pubmed:issue10lld:pubmed
pubmed-article:15128762pubmed:dateCreated2004-5-6lld:pubmed
pubmed-article:15128762pubmed:abstractTextTo date, immunoreceptor tyrosine-based inhibition motifs (ITIMs) have been shown to mediate inhibitory properties. We report a novel triggering receptor expressed on myeloid cells (TREM) family member, TREM-like transcript-1 (TLT1), which differs from the activating members because its cytoplasmic tail contains two ITIMs at Y245 and Y281. A TLT1 splice variant (TLT1sp) encodes a different cytoplasmic tail lacking ITIMs. Both isoforms are expressed in resting platelet alpha-granules, which are up-regulated to the cell surface following activation. TLT1 recruited Src homology 2 domain-containing tyrosine phosphatase (SHP)-2 to the "classical" ITIM (Y281) but not the "nonclassical" ITIM (Y245). In contrast to previously characterized ITIM receptors, TLT1 enhanced, rather than inhibited, FcepsilonRI-mediated calcium signaling in rat basophilic leukemia cells, a property dependent on the SHP-2 recruiting classical Y281 ITIM. Therefore, TLT1 represents a new costimulatory ITIM immunoreceptor and is the second ITIM-bearing receptor to be identified in platelets after platelet endothelial cell adhesion molecule-1.lld:pubmed
pubmed-article:15128762pubmed:languageenglld:pubmed
pubmed-article:15128762pubmed:journalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:citationSubsetAIMlld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:chemicalhttp://linkedlifedata.com/r...lld:pubmed
pubmed-article:15128762pubmed:statusMEDLINElld:pubmed
pubmed-article:15128762pubmed:monthMaylld:pubmed
pubmed-article:15128762pubmed:issn0022-1767lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:AlexanderDeni...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:TrowsdaleJohn...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:FarndaleRicha...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:SmithKenneth...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:BrookeGaryGlld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:RelouIngrid...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:AstoulEmmanue...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:BarrowAlexand...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:JenningsNicol...lld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:FlotoAndresAlld:pubmed
pubmed-article:15128762pubmed:authorpubmed-author:OuwehandWille...lld:pubmed
pubmed-article:15128762pubmed:issnTypePrintlld:pubmed
pubmed-article:15128762pubmed:day15lld:pubmed
pubmed-article:15128762pubmed:volume172lld:pubmed
pubmed-article:15128762pubmed:ownerNLMlld:pubmed
pubmed-article:15128762pubmed:authorsCompleteYlld:pubmed
pubmed-article:15128762pubmed:pagination5838-42lld:pubmed
pubmed-article:15128762pubmed:dateRevised2007-11-15lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:meshHeadingpubmed-meshheading:15128762...lld:pubmed
pubmed-article:15128762pubmed:year2004lld:pubmed
pubmed-article:15128762pubmed:articleTitleCutting edge: TREM-like transcript-1, a platelet immunoreceptor tyrosine-based inhibition motif encoding costimulatory immunoreceptor that enhances, rather than inhibits, calcium signaling via SHP-2.lld:pubmed
pubmed-article:15128762pubmed:affiliationCambridge Institute for Medical Research, Wellcome Trust, Addenbrookes Hospital, Cambridge, United Kingdom. adb44@cam.ac.uklld:pubmed
pubmed-article:15128762pubmed:publicationTypeJournal Articlelld:pubmed
pubmed-article:15128762pubmed:publicationTypeResearch Support, Non-U.S. Gov'tlld:pubmed
entrez-gene:5781entrezgene:pubmedpubmed-article:15128762lld:entrezgene
entrez-gene:340205entrezgene:pubmedpubmed-article:15128762lld:entrezgene
entrez-gene:25622entrezgene:pubmedpubmed-article:15128762lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15128762lld:entrezgene
http://linkedlifedata.com/r...entrezgene:pubmedpubmed-article:15128762lld:entrezgene
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
http://linkedlifedata.com/r...pubmed:referesTopubmed-article:15128762lld:pubmed
More...